key: cord-0875725-2ufhja7p authors: RAHMAN, MOHAMMAD MESHBAHUR; BHATTACHARJEE, BADHAN; FARHANA, ZAKI; HAMIDUZZAMAN, MOHAMMAD; CHOWDHURY, MUHAMMAD ABDUL BAKER; HOSSAIN, MOHAMMAD SOROWAR; SIDDIQEE, MAHBUBUL H.; ISLAM, MD. ZIAUL; RAHEEM, ENAYETUR; UDDIN, MD. JAMAL title: Age-related risk factors and severity of SARS-CoV-2 infection: a systematic review and meta-analysis date: 2021-07-30 journal: J Prev Med Hyg DOI: 10.15167/2421-4248/jpmh2021.62.2.1946 sha: 920bb34a4aa479278321c7d8d8638e86beb082bb doc_id: 875725 cord_uid: 2ufhja7p OBJECTIVES: We aimed to estimate the prevalence of reported symptoms and comorbidities, and investigate the factors associated with age of the SARS-CoV-2 infected patients. METHODS: We performed a systematic review with meta-analysis (PROSPERO registration: CRD42020182677) where the databases (PubMed, SCOPUS, EMBASE, WHO, Semantic Scholar, and COVID-19 Primer) were searched for clinical studies published from January to April, 2020. Initially, the pooled prevalence of symptoms and comorbidity of COVID-19 patients were estimated using random effect model and the age –related factors were identified performing multivariate analysis [factor analysis]. RESULTS: Twenty-nine articles with 4,884 COVID-19 patients were included in this study. Altogether, we found 33 symptoms and 44 comorbidities where the most frequent 19 symptoms and 11 comorbidities were included in the meta-analysis. The fever (84%), cough/dry cough (61%), and fatigue/weakness (42%) were found more prevalent while acute respiratory distress syndrome, hypertension and diabetes were the most prevalent comorbid condition. The factor analysis showed positive association between a cluster of symptoms and comorbidities with patients’ age. The symptoms comprising fever, dyspnea/shortness of breath, nausea, vomiting, abdominal pain, dizziness, anorexia and pharyngalgia; and the comorbidities including diabetes, hypertension, coronary heart disease, COPD/lung disease and ARDS were the factors positively associated with COVID-19 patient’s age. CONCLUSION: As an unique effort, this study found a group of symptoms (fever, dyspnea/shortness of breath, nausea, vomiting, abdominal pain, dizziness, anorexia and pharyngalgia) and comorbidities (diabetes, hypertension, coronary heart disease, COPD/lung disease and ARDS), associated with the age of COVID-19 infected patients. The COVID-19 pandemic caused by Severe Acute Respiratory Virus 2 (SARS-CoV-2) is a serious public health crisis in the history of humanity. Originated in Wuhan, China, SARS-CoV-2 has spread to every corner of the world within a few months. As of March 22, 2021 , over 123 million confirmed cases and 2.72 million deaths have been reported from over 219 countries [1] . As the virus is moving fast, various clinical spectrum and differential clinical outcomes are unfolding across different geographic locations. Several symptoms have been reported which includes fever, cough, myalgia, sputum production, headache, hemoptysis, diarrhea, and dyspnea [2] . The severity of COVID-19 has been reported to be linked with various host factors including diabetes, hypertension, cardiovascular disease, chronic obstructive pulmonary disease (COPD), malignancy, and chronic liver disease [2] . While susceptibility to COVID-19 covers all age groups, people with compromised immune systems and or having comorbidity are at a higher risk [3, 4] . A few review studies investigated symptoms and comorbidities of the COVID-19 infected patients with a shorter time-frame [3, [5] [6] [7] [8] . The mortality rate is high in older COVID-19 patients with organ dysfunctions comprising shock, acute respiratory distress syndrome (ARDS), acute cardiac injury, and acute kidney injury [9] . However, there is a scarce information regarding the relationship between symptoms, comorbidities, and age of the COVID-19 patients. The objective of this study was to estimate the prevalence of all reported symptoms and comorbidities, and then identified the risk factors associated with age of COVID-19 infected patients. patients ranging from 25 to 100%), cough/dry cough (22-92%) and myalgia or muscle ache (3-63%) as common symptoms of COVID-19. Other reported symptoms were: headache (3-66%); diarrhea (3-48%) ; fatigue/weakness (9-85%); dyspnea/shortness of breath (1-88%); sputum production or expectoration (4-42%); vomiting (1-19%) ; nausea (4-27%) ; chest tightness (7-55%); and sore throat (5-32%) . For the comorbidities, about 93% and 86% of studies reported two comorbidities: diabetes (2 to 35%) and hypertension (8-50%) . Other prevalent comorbidities were chronic obstructive pulmonary disease (COPD)/ lung infection (0.2-38%); cardiovascular disease (5-23%); chronic liver disease (1-29%); malignancy (1-7%); coronary heart disease (1-33%); cerebrovascular disease (1-19%) ; chronic renal disease (1-8%); chronic kidney disease (1-29%); and Acute respiratory distress syndrome (ARDS) (17-100%) . The less reported symptoms and comorbidities were presented in Supplementary Table S1 . We meta-analysed 19 symptoms and 11 comorbidities, using random effect models that were reported in at least five selected articles . Meta-analysis showed a higher prevalence of fever (pooled prevalence: 84, 95% confidence interval (CI): 80-88%) and cough/dry cough (61, ; followed by fatigue/weakness (42, ; dyspnea/shortness of breath (39, ; headache and diarrhea (12, ; sore throat (15, ; myalgia/muscle ache and sputum production/expectoration (24, ; rhinorrhea (13, 95% CI: 4-26%); chest tightness (25, 95% CI: 15-31%); and anorexia (26, . The less prevalent symptoms were: chest pain (3%), nausea (8%), vomiting (6%), abdominal pain (4%), dizziness (5%), pharyngalgia (7%), and hemoptysis (2%). The most prevalent comorbidities were ARDS (61, (95) (96) (97) , hypertension (23, , and diabetes (12, 95% CI: 9-15%), followed by cardiovascular disease (10, ; coronary heart disease (7, 95% CI: 3-12%); cerebrovascular disease (6, 95% CI: 2-08%); COPD/lung disease (3, 95% CI: 02-50%); chronic liver disease (05, 95% CI: 03-07%); chronic Renal disease (0.01, 95% CI: 00%-03%); chronic Kidney disease (05, 95% CI: 02-10%); and malignancy (03, 95% CI: 02-04%). There was a high heterogeneity (I 2 ranged from 85 to 97%, Cochran Q-statistic p < 0.001) in all the prevalence of symptoms, except chest pain (I 2 = 0%, Cochran Q-statistic p < 0.95); abdominal pain (I 2 = 22.89%, Cochran Q-statistic p < 0.26); dizziness (I 2 = 64.21%, Cochran Q-statistic p < 0.002); and haemoptysis (I 2 = 63.48%, Cochran Q-statistic p < 0.01). In the case of comorbidities, the heterogeneity was found higher in almost all the comorbidities (I 2 ranged from 68.06 to 98.01%, Cochran Q-statistic p < 0.001) (Tab. II). Nineteen symptoms and 11 comorbidities were categorized into: symptom group and comorbidity group to determine the association between symptoms/ comorbidities and age of the COVID-19 patients (Fig. 2) . In factor analysis, the correlation circle represented between/within-group integration with the patients' age. The longer vectors indicated more influential than others, and the vectors that were close to each other with the same direction indicated a highly positive association. Vectors that were the opposite direction showed a negative association, and the vectors with an almost 90-degree angle demonstrated no association. The first principal component showed 31.59% variation and the second one showed 20.45% variation in the dataset. In symptom group, fever, dyspnea/shortness of breath, nausea, vomiting, abdominal pain, dizziness, anorexia, and pharyngalgia were found positively associated with the COVID-19 patients' age. In contrast, sore throat, headache, rhinorrhea, myalgia/muscle ache, fatigue, and hemoptysis were negatively associated with age. Similarly, in the comorbidity group, diabetes, hypertension, coronary heart disease, COPD/lung disease, and ARDS were in the same direction and positively associated with the age of the COVID-19 infected patients. The symptoms like chest tightness/ pain and the comorbidities, including chronic liver and kidney diseases, showed no association with the patients' age. Considering group integration, the fever, dyspnea/ shortness of breath, dizziness, pharyngalgia, and anorexia in the symptom group were positively associated with diabetes, ARDS, and kidney, cardiovascular, and liver diseases in comorbidity group. The symptoms like diarrhea, nausea, vomiting, and abdominal pain were positively associated with hypertension, coronary heart disease, and COPD/lung disease. The symptoms of sore throat, headache, rhinorrhea, myalgia/muscle ache, fatigue, and hemoptysis were positively associated with cerebrovascular disease (Fig. 2) . We aimed to estimate the prevalence of all reported symptoms and comorbidities, and investigate the factors associated with age of patients tested positive in COVID-19. In our selected 29 studies, the ratio Group association of symptoms and comorbidities with age of the COVID-19 patients (Symptom Group: S1: Fever, S2: Cough/Dry cough, S3: Fatigue, S4: Dyspnea/Shortness of breath, S5: Headache, S6: Diarrhea, S7: Sore Throat, S8: Myalgia/Muscle Ache, S9: Rhinorrhea, S10: Sputum Production/Expectoration, S11: Chest tightness, S12: Chest pain, S13: Nausea, S14: Vomiting, S15: Abdominal Pain, S16: Dizziness, S17: Anorexia, S18: Pharyngalgia, S19: Haemoptysis. of infection was reported higher in males than in females (100:82.5), and this result is consistent with previous studies [2, 5, 27, 45] . It is generally assumed that males are more likely to be infected by bacteria and viruses than females, because of the women's robust innate and adaptive immune responses [3, 46] . Moreover, males are more vulnerable to infectious disease because of different patterns of occupation, social communication, and lifestyle than females. Furthermore, in many developing countries, women are housewives who stay at home and have little contact with others [47] . We found 33 symptoms and 43 comorbidities in the studies, and our meta-analysis included most reported 19 symptoms and 11 comorbidities. Fever, cough/dry cough, fatigue, dyspnea, anorexia, chest tightness, myalgia, sore throat, rhinorrhea, headache, and diarrhea were highly prevalent symptoms where the others symptoms were found rarely. All studies reported fever (84%) and cough/dry cough (61%) as symptoms consistent with relevant studies across the countries [19, 23, 25, 48] . Previous studies reported hypertension as the most common comorbidity [3, 6, 7] , but our study suggests three major comorbidities -acute respiratory distress syndrome (61%), hypertension (23%), and diabetes (12%). Acute respiratory distress syndrome was found a higher prevalence rate (61%) as reported in three studies in China and one in outside China [28, 32, 36, 44] . We observed that the symptoms like anorexia (26%), chest tightness (25%) and rhinorrhea (13%), and one comorbidity, i.e., acute respiratory distress syndrome (61%) were examined with significant prevalence, but they were under-reported in the published systematic reviews [5, 6, 49, 50] . Human aging is associated with declines in adaptive and innate immunity, and it loses the body's ability to protect against infections [51] [52] [53] . Virologists and clinicians agree that the older adults are more vulnerable to COVID-19, and the patient's age can strongly be associated with symptoms and comorbidities [30, [54] [55] [56] [57] . Our multivariate analysis revealed that a cluster of symptoms, including fever, dyspnea/shortness of breath, nausea, vomiting, abdominal pain, dizziness, anorexia, and pharyngalgia, as well as a cluster of comorbidities, including diabetes, hypertension, coronary heart disease, COPD/lung disease, and ARDS, were positively associated with the age of COVID-19 infected patients. The Centers for Disease Control and Prevention (CDC) suggested that the older adults are more likely to be asymptomatic and they are at greater risk of requiring hospitalization or dying if they are diagnosed with COVID-19 [58] . The comorbid conditions (e.g. hypertension, heart problems, diabetes) and disease symptoms were more severe in the elderly age than any other age groups [59] [60] [61] [62] [63] . In a study, Wu Z and the authors reported that the COVID-19 infected elderly aged above 80 years had a higher case fatality rate (14.8 vs 8.0%) than 70-80 years aged peoples [64] . The World Health Organization (WHO) reported that older people with pre-existing medical conditions including asthma, diabetes, and heart disease appear to be more vulnerable to becoming severely ill with the virus and this findings supports to many other studies [65] [66] [67] [68] . During literature search, we were limited to only in English texts within the time frame January to April, 2020. The majority of the studies were found in China, and only five from other countries. More studies outside of China could add value in prevalence estimation. We found no data for <10 years children and thus, more studies are warranted in the child COVID-19 patients. Lastly, a few studies were found low sample size. This review study is the unique effort of its kind that estimated all frequent symptoms and comorbidities, and determines the age related risk factors of the COVID-19 patients. We found a cluster of symptoms and comorbidities that were the age associated risk factors of patients infected in COVID-19. Thus, in very early stages of SARS-CoV-2 infection, if a patient exhibits any of the symptoms within the cluster, this patient should be isolated and the necessary actions should be taken. Our findings also suggest a prioritize vaccination by age groups and older people with underlying conditions. Finally, policymakers should develop a comprehensive mass media campaign to educate the general population about these symptoms and comorbidities. The full list of data and the data entries for all included studies is provided in the manuscript as a supplementary file. No additional supporting data is available. E341 S1 (Continued). Characteristics of studies that evaluated the age related risk factors of COVID-19 patients. 2019?gclid=CjwKCAjw_ qb3BRAVEiwAvwq6Vt-GmIUuwPJFjbas_BZ-1QDXWD-cv1yGc-kl53oqrCkB1rxZV4SyfahoC69QQAvD_BwE Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis Clinical characteristics of 2019 novel infected coronavirus pneumonia. A systemic review and meta-analysis Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection Prevalence of comorbidities in COVID-19 patients: a systematic review and meta-analysis Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation The Global Case-Fatality Rate of COV-ID-19 Has Been Declining Since Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data Interpretation of random effects meta-analyses Hypertension prevalence and its trend in Bangladesh: evidence from a systematic review and meta-analysis Simultaneous analysis of distinct Omics data sets with integration of biological knowledge: Multiple Factor Analysis approach Integrating overweight-obesity and reproductive factors of married women in Bangladesh Clinical features and treatment of COVID-19 patients in northeast Chongqing Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei Clinical and immunological features of severe and moderate coronavirus disease 2019 Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China Clinical Characteristics of Coronavirus Disease 2019 in China Clinical features of COVID-19 in elderly patients: a comparison with young and middleaged patients Effect of Gastrointestinal Symptoms in Patients With COVID-19 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 Clinical Characteristics of Covid-19 in SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms Covid Working Group SH. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes Korea National Committee for Clinical Management of COVID-19. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19 Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up Radiological findings from 81 patients with COV-ID-19 pneumonia in Wuhan, China: a descriptive study Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients Sexual dimorphism in innate immunity More women stay at home than men. Yale-Global Online Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis Frailty indexed classification of Bangladeshi older adults' physio-psychosocial health and associated risk factors-a cross-sectional survey study Immune system dysfunction in the elderly Aging of the immune system: mechanisms and therapeutic targets Seniors with Covid-19 show unusual symptoms, doctors say COVID-19) outbreak -Statement -Older people are at highest risk from COVID-19, but all must act to prevent community spread Coronavirus pandemic: elderly more vulnerable to the disease; here's what doctors have to say Older adults and COVID-19 Hypertension and its physio-psychosocial risks factors in elderly people: a crosssectional study in north-eastern region of Bangladesh Factors affecting health status of urban aged population: evidence from Sylhet Biodemography of aging: determinants of healthy life span and longevity Health status and modeling of urban aged population of Sylhet District in Bangladesh Frailty in older adults: evidence for a phenotype Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention WHO. Coronavirus disease (COVID-19) advice for the public: Mythbusters Why does COV-ID-19 disproportionately affect older people? Comorbidity and its Impact on Patients with COVID-19 Age is not the only risk factor in COVID-19: the role of comorbidities and of long staying in residential care homes N=1099) (30 provincees, China) N=1099) (30 provincees, China) S8. Sore Throat Overall N=62) (Zhejiang, China) Study Guan et al. (N=1099) (30 provincees, China) N=1099) (30 provincees, China) S15. Vomiting Overall N=1099) (30 provincees S22. Hypertension Overall N=1099) (30 provincees N=1099) (30 provincees, China) N=1099) (30 provincees S26. COPD/Lung disease Overall N=1099) (30 provincees, China) S27. Chronic liver disease Overall N=1099) (30 provincees S29. Chronic Kidney disease Overall N=1099) (30 provincees, China) N=1099) (30 provincees, China) Funding sources: this research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. We acknowledge the authors of the selected research articles. We also acknowledge Mr. Saiful Islam (public health assistant) who supported and provided computer and necessary software during the data analysis. The authors declare no conflict of interest. MMR contributed to conceptualization, design and supervision of the study. MMR, BB and ZF